84 related articles for article (PubMed ID: 26757861)
1. [Association between genotype and allele frequencies of CYP2A6*12 and rs16969968 in CHRNA5 variants with smoking and body mass index in young subjects from Northeast Mexico].
Borrego-Soto G; Costilla-Esquivel A; Padilla-Rivas GR; Cázares-Samaniego PJ; Posadas-Valay R; Velasco-Castañón JG; Mercado-Longoria R; Ortiz-López R; Rojas-Martínez A
Rev Med Chil; 2015 Nov; 143(11):1377-85. PubMed ID: 26757861
[TBL] [Abstract][Full Text] [Related]
2. Nicotinic acetylcholine gene cluster CHRNA5-A3-B4 variants influence smoking status in a Bangladeshi population.
Chaity NI; Sultana TN; Hasan MM; Shrabonee II; Nahid NA; Islam MS; Apu MNH
Pharmacol Rep; 2021 Apr; 73(2):574-582. PubMed ID: 33675519
[TBL] [Abstract][Full Text] [Related]
3. Lung cancer risk in relation to nicotinic acetylcholine receptor, CYP2A6 and CYP1A1 genotypes in the Bangladeshi population.
Islam MS; Ahmed MU; Sayeed MS; Maruf AA; Mostofa AG; Hussain SM; Kabir Y; Daly AK; Hasnat A
Clin Chim Acta; 2013 Feb; 416():11-9. PubMed ID: 23178447
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms in CYP2A6 are associated with a risk of cigarette smoking and predispose to smoking at younger ages.
Pérez-Rubio G; López-Flores LA; Ramírez-Venegas A; Noé-Díaz V; García-Gómez L; Ambrocio-Ortiz E; Sánchez-Romero C; Hernández-Zenteno RJ; Sansores RH; Falfán-Valencia R
Gene; 2017 Sep; 628():205-210. PubMed ID: 28734893
[TBL] [Abstract][Full Text] [Related]
5. CHRNA5-A3-B4 genetic variants alter nicotine intake and interact with tobacco use to influence body weight in Alaska Native tobacco users.
Zhu AZ; Renner CC; Hatsukami DK; Benowitz NL; Tyndale RF
Addiction; 2013 Oct; 108(10):1818-28. PubMed ID: 23692359
[TBL] [Abstract][Full Text] [Related]
6. The polymorphism of the CHRNA5 gene and the strength of nicotine addiction in lung cancer and COPD patients.
Wojas-Krawczyk K; Krawczyk P; Biernacka B; Grzybek M; Kołodziej P; Kucharczyk T; Mlak R; Milanowski J
Eur J Cancer Prev; 2012 Mar; 21(2):111-7. PubMed ID: 21955800
[TBL] [Abstract][Full Text] [Related]
7. [Relation of genetic variants of CYP2A6 with tobacco dependence and smoking habit in Chilean subjects. A pilot study].
Cáceres DD; Alvarado SA; Martínez P; Quiñones LA
Rev Med Chil; 2012 Apr; 140(4):436-41. PubMed ID: 22854688
[TBL] [Abstract][Full Text] [Related]
8. Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk.
Wassenaar CA; Dong Q; Wei Q; Amos CI; Spitz MR; Tyndale RF
J Natl Cancer Inst; 2011 Sep; 103(17):1342-6. PubMed ID: 21747048
[TBL] [Abstract][Full Text] [Related]
9. Associations of CYP2A6 Gene Polymorphism with Smoking Status Among Jordanians: Gender-Related Differences.
Hammad HM; Imraish A; Azab B; Best AM; Khader YS; Zihlif M
Curr Drug Metab; 2019; 20(9):765-770. PubMed ID: 31453782
[TBL] [Abstract][Full Text] [Related]
10. [Association of the nicotine and cigarette smoke toxicants metabolic (CHRNA3/5, CYP2A6, NQO1) and DNA repair genes (XRCC1, XRCC3, XPC, XPA) with chronic obstructive pulmonary disease].
Korytina GF; Akhmadishina LZ; Kochetova OV; Burdiuk IuV; Aznabaeva IuG; Zagidullin ShZ; Victorova TV
Mol Biol (Mosk); 2014; 48(6):939-51. PubMed ID: 25845234
[TBL] [Abstract][Full Text] [Related]
11. Combined analysis of CHRNA5, CHRNA3 and CYP2A6 in relation to adolescent smoking behaviour.
Rodriguez S; Cook DG; Gaunt TR; Nightingale CM; Whincup PH; Day IN
J Psychopharmacol; 2011 Jul; 25(7):915-23. PubMed ID: 21765098
[TBL] [Abstract][Full Text] [Related]
12. Relationship between CYP2A6 genetic polymorphism, as a marker of nicotine metabolism, and ulcerative colitis.
Altarescu G; Rachmilewitz D; Zevin S
Isr Med Assoc J; 2011 Feb; 13(2):87-90. PubMed ID: 21443033
[TBL] [Abstract][Full Text] [Related]
13. SNPs within CHRNA5-A3-B4 and CYP2A6/B6, nicotine metabolite concentrations and nicotine dependence treatment success in smokers.
Hubacek JA; Kurcova I; Maresova V; Pankova A; Stepankova L; Zvolska K; Lanska V; Kralikova E
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2021 Mar; 165(1):84-89. PubMed ID: 31796940
[TBL] [Abstract][Full Text] [Related]
14. 'Smoking genes': a genetic association study.
Verde Z; Santiago C; Rodríguez González-Moro JM; de Lucas Ramos P; López Martín S; Bandrés F; Lucia A; Gómez-Gallego F
PLoS One; 2011; 6(10):e26668. PubMed ID: 22046326
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants in CYP2A6 and UGT1A9 genes associated with urinary nicotine metabolites in young Mexican smokers.
Borrego-Soto G; Perez-Paramo YX; Chen G; Santuario-Facio SK; Santos-Guzman J; Posadas-Valay R; Alvarado-Monroy FM; Balderas-Renteria I; Medina-Gonzalez R; Ortiz-Lopez R; Lazarus P; Rojas-Martinez A
Pharmacogenomics J; 2020 Aug; 20(4):586-594. PubMed ID: 31959879
[TBL] [Abstract][Full Text] [Related]
16. Association of CYP2A6*1B genetic variant with the amount of smoking in French adults from the Stanislas cohort.
Gambier N; Batt AM; Marie B; Pfister M; Siest G; Visvikis-Siest S
Pharmacogenomics J; 2005; 5(4):271-5. PubMed ID: 15940289
[TBL] [Abstract][Full Text] [Related]
17. Association of genes coding for the alpha-4, alpha-5, beta-2 and beta-3 subunits of nicotinic receptors with cigarette smoking and nicotine dependence.
Etter JF; Hoda JC; Perroud N; Munafò M; Buresi C; Duret C; Neidhart E; Malafosse A; Bertrand D
Addict Behav; 2009 Sep; 34(9):772-5. PubMed ID: 19482438
[TBL] [Abstract][Full Text] [Related]
18. CYP2A6 allele frequencies in an Iranian population.
Emamghoreishi M; Bokaee HR; Keshavarz M; Ghaderi A; Tyndale RF
Arch Iran Med; 2008 Nov; 11(6):613-7. PubMed ID: 18976031
[TBL] [Abstract][Full Text] [Related]
19. Single nucleotide polymorphisms in CHRNA5 rs16969968, CHRNA3 rs578776, and LOC123688 rs8034191 are associated with heaviness of smoking in women in Northeastern Ontario, Canada.
Conlon MS; Bewick MA
Nicotine Tob Res; 2011 Nov; 13(11):1076-83. PubMed ID: 21810735
[TBL] [Abstract][Full Text] [Related]
20. CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis.
Chen LS; Hung RJ; Baker T; Horton A; Culverhouse R; Saccone N; Cheng I; Deng B; Han Y; Hansen HM; Horsman J; Kim C; Lutz S; Rosenberger A; Aben KK; Andrew AS; Breslau N; Chang SC; Dieffenbach AK; Dienemann H; Frederiksen B; Han J; Hatsukami DK; Johnson EO; Pande M; Wrensch MR; McLaughlin J; Skaug V; van der Heijden HF; Wampfler J; Wenzlaff A; Woll P; Zienolddiny S; Bickeböller H; Brenner H; Duell EJ; Haugen A; Heinrich J; Hokanson JE; Hunter DJ; Kiemeney LA; Lazarus P; Le Marchand L; Liu G; Mayordomo J; Risch A; Schwartz AG; Teare D; Wu X; Wiencke JK; Yang P; Zhang ZF; Spitz MR; Kraft P; Amos CI; Bierut LJ
J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25873736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
